These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7421277)

  • 21. Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma: a phase II FONICAP trial. Italian Lung Cancer Task Force.
    Pennucci MC; Ardizzoni A; Pronzato P; Fioretti M; Lanfranco C; Verna A; Giorgi G; Vigani A; Frola C; Rosso R
    Cancer; 1997 May; 79(10):1897-902. PubMed ID: 9149015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic approaches in malignant mesothelioma.
    Legha SS; Muggia FM
    Cancer Treat Rev; 1977 Mar; 4(1):13-23. PubMed ID: 66990
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mesothelioma as an index tumor of the occupational hazard of asbestos dust].
    Woitowitz HJ; Paur R; Breuer G; Rödelsperger K
    Dtsch Med Wochenschr; 1984 Mar; 109(10):363-8. PubMed ID: 6697895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy of diffuse malignant mesothelioma. Phase II trials of single-agent 5-fluorouracil and adriamycin.
    Harvey VJ; Slevin ML; Ponder BA; Blackshaw AJ; Wrigley PF
    Cancer; 1984 Sep; 54(6):961-4. PubMed ID: 6467141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathologic study of pleural and peritoneal mesotheliomas of rats induced by asbestos].
    Tan XM
    Zhonghua Bing Li Xue Za Zhi; 1991 Sep; 20(3):187-9. PubMed ID: 1782687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Palliative chemotherapy of adult soft tissue sarcomas with an association of cyclophosphamide-vincristine-adriamycine-dacarbazine (CYVADIC) (author's transl)].
    Bui B; Chauvergne J; Durand M; Brunet R
    Bull Cancer; 1981; 68(1):1-5. PubMed ID: 7225604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy of malignant mesothelioma.
    Gerner RE; Moore GE
    Oncology; 1974; 30(2):152-5. PubMed ID: 4217436
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.
    Yap BS; Baker LH; Sinkovics JG; Rivkin SE; Bottomley R; Thigpen T; Burgess MA; Benjamin RS; Bodey GP
    Cancer Treat Rep; 1980 Jan; 64(1):93-8. PubMed ID: 7379060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Incidence of malignant mesothelioma (1980-1999) and asbestos exposure in 190 cases diagnosed among residents of the province of Brescia].
    Barbieri PG; Lombardi S; Candela A; Pezzotti C; Binda I
    Med Lav; 2001; 92(4):249-62. PubMed ID: 11676187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Malignant mesothelioma of the peritoneum. Case report].
    Richter B; Richter P; Buchholz K
    Zentralbl Gynakol; 1983; 105(9):598-601. PubMed ID: 6880476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study.
    Fizazi K; Doubre H; Le Chevalier T; Riviere A; Viala J; Daniel C; Robert L; Barthélemy P; Fandi A; Ruffié P
    J Clin Oncol; 2003 Jan; 21(2):349-54. PubMed ID: 12525529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Malignant mesothelioma in Basse-Normandie, a French population study. Descriptive analysis, prognostic factors and survival].
    Desoubeaux N; Bouvier V; Gervais R; Galateau-Salle F; Thibon P; Leplumey T; Herbert C; Lecherbonnier Y; Daviet JP; Letourneux M
    Rev Epidemiol Sante Publique; 2001 Dec; 49(6):523-9. PubMed ID: 11845101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant mesothelioma: attributable risk of asbestos exposure.
    Spirtas R; Heineman EF; Bernstein L; Beebe GW; Keehn RJ; Stark A; Harlow BL; Benichou J
    Occup Environ Med; 1994 Dec; 51(12):804-11. PubMed ID: 7849863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.
    Chahinian AP; Antman K; Goutsou M; Corson JM; Suzuki Y; Modeas C; Herndon JE; Aisner J; Ellison RR; Leone L
    J Clin Oncol; 1993 Aug; 11(8):1559-65. PubMed ID: 8336195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of six cases of mesothelioma with doxorubicin and cisplatin.
    Zidar BL; Pugh RP; Schiffer LM; Raju RN; Vaidya KA; Bloom RL; Horne D; Baker LH
    Cancer; 1983 Nov; 52(10):1788-91. PubMed ID: 6684983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asbestos-related mesothelioma: factors discriminating between pleural and peritoneal sites.
    Browne K; Smither WJ
    Br J Ind Med; 1983 May; 40(2):145-52. PubMed ID: 6299326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-malignant chest x ray changes in patients with mesothelioma in a large cohort of asbestos insulation workers.
    Lilis R; Ribak J; Suzuki Y; Penner L; Bernstein N; Selikoff IJ
    Br J Ind Med; 1987 Jun; 44(6):402-6. PubMed ID: 3606969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case report of malignant pleural mesothelioma with long-term disease control after chemotherapy.
    Umsawasdi T; Dhingra HM; Charnsangavej C; Luna MA
    Cancer; 1991 Jan; 67(1):48-54. PubMed ID: 1898706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases.
    Roggli VL; Sharma A; Butnor KJ; Sporn T; Vollmer RT
    Ultrastruct Pathol; 2002; 26(2):55-65. PubMed ID: 12036093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesothelioma in a factory using amosite and chrysotile asbestos.
    Acheson ED; Bennett C; Gardner MJ; Winter PD
    Lancet; 1981 Dec 19-26; 2(8260-61):1403-6. PubMed ID: 6118770
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.